Cargando…

Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?

SIMPLE SUMMARY: Resistance to tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer is crucial in the development of the disease. Detecting the mechanisms of this resistance is fundamental in lung cancer research, so we evaluated the presence of EGFR mutations in circul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alen, Begoña O., Estévez-Pérez, Lara S., Hermida-Romero, María Teresa, Reguera-Arias, Ana, García-Campelo, Rosario, de la Torre-Bravos, Mercedes, Concha, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313361/ https://www.ncbi.nlm.nih.gov/pubmed/35884384 http://dx.doi.org/10.3390/cancers14143323

Ejemplares similares

Molecular Detection of Lymph Node Metastases in Lung Cancer Patients Using the One-Step Nucleic Acid Amplification Method:Clinical Significance and Prognostic Value
por: Hermida-Romero, María Teresa, et al.
Publicado: (2022)

Detection of lymph node metastasis in lung cancer patients using a one-step nucleic acid amplification assay: a single-centre prospective study
por: Escalante Pérez, María, et al.
Publicado: (2019)

Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles as a Diagnostic Tool for Neoplastic Processes
por: Alen, Begoña O., et al.
Publicado: (2023)

FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2
por: Jiménez-Izquierdo, Rafael, et al.
Publicado: (2023)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
por: Jiao, Qinlian, et al.
Publicado: (2018)

Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor
por: Fujino, Toshio, et al.
Publicado: (2021)

The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer
por: Boni, Christian, et al.
Publicado: (2022)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

FGFR3 has tumor suppressor properties in cells with epithelial phenotype
por: Lafitte, Marie, et al.
Publicado: (2013)

ADAMTS-15 Has a Tumor Suppressor Role in Prostate Cancer
por: Binder, Marley J., et al.
Publicado: (2020)

Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
por: Sierra, J Rafael, et al.
Publicado: (2010)

LINC00483 Has a Potential Tumor-Suppressor Role in Colorectal Cancer Through Multiple Molecular Axes
por: Brex, Duilia, et al.
Publicado: (2021)

Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis()()()
por: Feng, Riyue, et al.
Publicado: (2018)

What has Changed in Community-Acquired Pneumonia in Recent Years?()
por: Alfageme Michavila, Inmaculada
Publicado: (2017)

Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants
por: Bekeschus, Sander
Publicado: (2021)

Conformational flexibility determines the Nf2/merlin tumor suppressor functions
por: Primi, Marina C., et al.
Publicado: (2021)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Early On-Treatment Prediction of the Mechanisms of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
por: Choi, Yu-ra, et al.
Publicado: (2022)

The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system
por: Lodeiro, Maria, et al.
Publicado: (2011)

NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
por: Wilson, C. L., et al.
Publicado: (2015)

In Vivo Functional Analysis of the Human NF2 Tumor Suppressor Gene in Drosophila
por: Gavilan, Heather S., et al.
Publicado: (2014)

Regulation of tyrosine-hydroxylase (TH) gene expression by hypoxia and von Hippel-Lindau tumor suppressor complex
por: Bauer, AL, et al.
Publicado: (2001)

LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer
por: Liu, Yifan, et al.
Publicado: (2023)

Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013)

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer
por: Ji, Wonjun, et al.
Publicado: (2013)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
por: Wu, Jialu, et al.
Publicado: (2020)

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors
por: Wagener-Ryczek, Svenja, et al.
Publicado: (2020)

Negative Regulation of NF-κB by the ING4 Tumor Suppressor in Breast Cancer
por: Byron, Sara A., et al.
Publicado: (2012)

Corrigendum: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
por: Wilson, C. L., et al.
Publicado: (2015)

Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration
por: Schulz, Alexander, et al.
Publicado: (2016)

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
por: Piekarska, Agnieszka, et al.
Publicado: (2015)

NF45 dimerizes with NF90, Zfr and SPNR via a conserved domain that has a nucleotidyltransferase fold
por: Wolkowicz, Urszula M., et al.
Publicado: (2012)

Community-acquired pneumonia in adults with Down syndrome. Three clinical cases and a review of the literature
por: Hermida Pérez, J.A., et al.
Publicado: (2010)

The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling
por: Drafahl, Kristine A., et al.
Publicado: (2010)

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
por: He, Ying, et al.
Publicado: (2021)

Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells.
por: Theobald, J., et al.
Publicado: (1995)

Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner
por: Lee, Yoonmi, et al.
Publicado: (2018)

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer
por: Guo, Renhua, et al.
Publicado: (2011)

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
por: Zhang, Shannon S., et al.
Publicado: (2022)

Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation
por: Sorokin, Maxim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b3srernnar1aj1aquk7rngo9ie